Moshe Papa

Medicine & Life Sciences

1. Breast Neoplasms 100%
2. Breast 41%
3. Neoplasms 41%
4. Mutation 37%
5. Thromboangiitis Obliterans 35%
6. Colonic Neoplasms 35%
7. Ovarian Neoplasms 33%
8. Liver 27%
9. Lymphokine-Activated Killer Cells 27%
10. Segmental Mastectomy 26%
11. Interleukin-2 25%
12. Jews 25%
13. Drug Therapy 25%
14. Germ-Line Mutation 24%
15. Familial Breast Cancer 22%
16. Extracellular Matrix 21%
17. BRCA1 Gene 20%
18. Hypothyroidism 19%
19. Hepatocytes 18%
20. Haplotypes 18%
21. Cell Line 17%
22. Melanoma 16%
23. Israel 16%
24. Intercellular Signaling Peptides and Proteins 15%
25. B72.3 antibody 15%
26. Neoplasm Metastasis 14%
27. Gastrectomy 14%
28. Rectal Neoplasms 14%
29. Prophylactic Mastectomy 14%
30. BRCA2 Gene 13%
31. Tyrosine 13%
32. Phosphorylation 13%
33. Thioacetamide 13%
34. Magnetic Resonance Spectroscopy 13%
35. Sp1 Transcription Factor 13%
36. Growth Factor Receptors 13%
37. Doxorubicin 12%
38. Tumor Necrosis Factor-alpha 12%
39. Insulin Receptor Substrate Proteins 12%
40. IGF Type 1 Receptor 11%
41. Perfusion 11%
42. Cyclophosphamide 11%
43. Therapeutics 11%
44. Insulin-Like Growth Factor I 11%
45. Pelvic Floor 11%
46. Morbidity 10%
47. Carcinoid Tumor 10%
48. Hemorrhage 10%
49. Troleandomycin 10%
50. Chemoprevention 10%